Evidence map›Paper›PMID 29073096›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Staufen1 inhibits MyoD translation to actively maintain muscle stem cell quiescence.

Antoine de Morrée, Cindy T J van Velthoven, Qiang Gan, Jayesh S Salvi, Julian D D Klein, Igor Akimenko, Marco Quarta, Stefano Biressi, Thomas A Rando

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. A who's who of cell types in skeletal muscle.Communications biology · 2026
    Review
  5. Article
  6. Article
  7. mRNA translational control of regeneration.Current opinion in genetics & development · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. How much do we know about the metastatic process?Clinical & experimental metastasis · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Antoine de MorréeDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.ORCID 0000-0002-8316-4531
Cindy T J van VelthovenDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Qiang GanDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Jayesh S SalviDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Julian D D KleinDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Igor AkimenkoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Marco QuartaDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Stefano BiressiDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Thomas A RandoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305; rando@stanford.edu.
Stanford University · USVA Palo Alto Health Care System · US

Funding

Wnt signaling in muscle stem cell agingP01AG036695 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI THOMAS A. RANDO · 2011 to 2026
$29.3M
Notch Signaling and Satellite Cell ActivationR37AG023806 · NIA · STANFORD UNIVERSITY · PI RANDO, THOMAS A. · 2010 to 2019
$2.9M
The Function and Regulation of Pax3 in Muscle Stem CellsR01AR062185 · NIAMS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RANDO, THOMAS A. · 2011 to 2015
$1.5M
Regulation of Muscle Fibrosis in Response to Injury and AgingI01BX002324 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI RANDO, THOMAS A. · 2014 to 2021
–
Muscle Stem Cell Therapy for Volumetric Muscle LossI01RX001222 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI HUANG, NGAN F. · 2014 to 2023
–
BLRD VA I01 BX002324NIAMS NIH HHS R01 AR062185NIA NIH HHS P01 AG036695NIA NIH HHS R37 AG023806
6 · The paper itself

Abstract

Tissue regeneration depends on the timely activation of adult stem cells. In skeletal muscle, the adult stem cells maintain a quiescent state and proliferate upon injury. We show that muscle stem cells (MuSCs) use direct translational repression to maintain the quiescent state. High-resolution single-molecule and single-cell analyses demonstrate that quiescent MuSCs express high levels of Myogenic Differentiation 1 (MyoD) transcript in vivo, whereas MyoD protein is absent. RNA pulldowns and costainings show that MyoD mRNA interacts with Staufen1, a potent regulator of mRNA localization, translation, and stability. Staufen1 prevents MyoD translation through its interaction with the MyoD 3'-UTR. MuSCs from Staufen1 heterozygous (Staufen1

Indexed as

AnimalsCell DifferentiationGene Expression RegulationMiceMuscle CellsMyoD ProteinRNA-Binding ProteinsRNA, MessengerStem CellsMyoD1 myogenic differentiation proteinMyoD ProteinRNA-Binding ProteinsRNA, MessengerStau1 protein, mousemuscle stem cellMyoDquiescencesatellite cellStaufen1

Identifiers

PMID29073096
PMCPMC5664522
OpenAlexW2762997208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.